Inflammation meets cancer, with NF-κB as the matchmaker

[1]  J. Ruland.  Return to homeostasis: downregulation of NF-κB responses , 2011, Nature Immunology.

[2]  S. Smale.  Hierarchies of NF-κB target-gene regulation , 2011, Nature Immunology.

[3]  L. Coussens,et al.  Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization , 2011, International journal of cancer.

[4]  Ulrich C. Klostermeier,et al.  Defining the origins of the NOD-like receptor system at the base of animal evolution. , 2011, Molecular biology and evolution.

[5]  H. Hieronymus,et al.  FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR , 2011, Nature.

[6]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[7]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[8]  J. Cheng,et al.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.

[9]  Steffen Jung,et al.  CKIα ablation highlights a critical role for p53 in invasiveness control , 2011, Nature.

[10]  Joseph M. Connors,et al.  Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.

[11]  I. Weissman,et al.  IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ , 2011, Nature Immunology.

[12]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[13]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[14]  M. Herridge.  NFKBIA Deletion in Glioblastomas , 2011 .

[15]  Francesca Demichelis,et al.  Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. , 2011, Genome research.

[16]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[17]  Paul Martin,et al.  Live Imaging of Innate Immune Cell Sensing of Transformed Cells in Zebrafish Larvae: Parallels between Tumor Initiation and Wound Inflammation , 2010, PLoS biology.

[18]  M. Widschwendter,et al.  Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer , 2010, Nature.

[19]  D. Branstetter,et al.  RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis , 2010, Nature.

[20]  D. Kerr,et al.  Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[22]  Mark Manfredi,et al.  MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. , 2010, Blood.

[23]  Todd H. Oakley,et al.  The Amphimedon queenslandica genome and the evolution of animal complexity , 2010, Nature.

[24]  J. Wright,et al.  Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy , 2010, Clinical Cancer Research.

[25]  KyungMann Kim,et al.  Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells , 2010, Molecular Cancer.

[26]  Julia B. Cordero,et al.  Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. , 2010, Developmental cell.

[27]  L. Staudt.  Oncogenic activation of NF-kappaB. , 2010, Cold Spring Harbor perspectives in biology.

[28]  Thomas J. Fuchs,et al.  TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. , 2010, Cancer cell.

[29]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[30]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[31]  Alberto Mantovani,et al.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.

[32]  M. Schön,et al.  NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. , 2010, The Journal of investigative dermatology.

[33]  A. Mantovani,et al.  Cancer and Inflammation: Implications for Pharmacology and Therapeutics , 2010, Clinical pharmacology and therapeutics.

[34]  R. Medzhitov.  Inflammation 2010: New Adventures of an Old Flame , 2010, Cell.

[35]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[36]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[37]  V. Dixit,et al.  Signaling to NF-kappaB: regulation by ubiquitination. , 2010, Cold Spring Harbor perspectives in biology.

[38]  M. Pagano,et al.  Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCF{beta}-TrCP by single substrate depletion. , 2010, Genes & development.

[39]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[40]  T. Bosch,et al.  How Hydra senses and destroys microbes. , 2010, Seminars in immunology.

[41]  Nir London,et al.  Ubiquitination and degradation of the inhibitors of NF-kappaB. , 2010, Cold Spring Harbor perspectives in biology.

[42]  Derek A. West,et al.  17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. , 2008, Blood.

[43]  M. Karin,et al.  Hepatocyte IKK β / NF-κ B inhibits tumor promotion and progression by preventing oxidative stress driven STAT 3 activation , 2010 .

[44]  Alexander Hoffmann,et al.  The regulatory logic of the NF-kappaB signaling system. , 2010, Cold Spring Harbor perspectives in biology.

[45]  V. Dixit,et al.  Signaling to NFk B : Regulation by Ubiquitination , 2010 .

[46]  L. Staudt,et al.  4924 , a NEDD 8-activating enzyme inhibitor , is active in diffuse large B-cell lymphoma models : rationale for treatment of NF-B – dependent lymphoma * , 2010 .

[47]  H. Marusawa,et al.  Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers , 2010, Journal of Gastroenterology.

[48]  M. Karin,et al.  B-cell-derived lymphotoxin promotes castration-resistant prostate cancer , 2010, Nature.

[49]  Diethard Tautz,et al.  Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa , 2010, BMC Biology.

[50]  S. Akira,et al.  Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis , 2009, Proceedings of the National Academy of Sciences.

[51]  N. Perrimon,et al.  Synergy between bacterial infection and genetic predisposition in intestinal dysplasia , 2009, Proceedings of the National Academy of Sciences.

[52]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[53]  M. Pasparakis,et al.  Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases , 2009, Nature Reviews Immunology.

[54]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[55]  K. McIntyre,et al.  Periodic, Partial Inhibition of IκB Kinase β-Mediated Signaling Yields Therapeutic Benefit in Preclinical Models of Rheumatoid Arthritis , 2009, Journal of Pharmacology and Experimental Therapeutics.

[56]  M. Kurrer,et al.  A lymphotoxin-driven pathway to hepatocellular carcinoma. , 2009, Cancer cell.

[57]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[58]  G. Natoli,et al.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Lauffenburger,et al.  Three-kinase inhibitor combination recreates multipathway effects of a geldanamycin analogue on hepatocellular carcinoma cell death , 2009, Molecular Cancer Therapeutics.

[60]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[61]  L. Staudt,et al.  Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. , 2009, Blood.

[62]  R. Dalla‐Favera,et al.  Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma , 2009, Nature.

[63]  Alexander A. Shishkin,et al.  Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors , 2009, Cell cycle.

[64]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[65]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[66]  C. Klemke,et al.  Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. , 2009, Cancer research.

[67]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[68]  Ozge Canli,et al.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.

[69]  M. Karin,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2009, Nature.

[70]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[71]  Alexander Hoffmann,et al.  The Regulatory Logic of the NFk B Signaling System , 2009 .

[72]  L. Staudt,et al.  Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screen , 2008, Proceedings of the National Academy of Sciences.

[73]  C. Eaves,et al.  Cancer stem cells: Here, there, everywhere? , 2008, Nature.

[74]  G. Bhagat,et al.  Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.

[75]  R. DeSalle,et al.  Evolution of MDA-5/RIG-I-dependent innate immunity: Independent evolution by domain grafting , 2008, Proceedings of the National Academy of Sciences.

[76]  M. Karin,et al.  Opposing functions of IKKβ during acute and chronic intestinal inflammation , 2008, Proceedings of the National Academy of Sciences.

[77]  Dung-Fang Lee,et al.  Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy , 2008, Clinical Cancer Research.

[78]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[79]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[80]  S. Nishikawa,et al.  NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells , 2008, Proceedings of the National Academy of Sciences.

[81]  T. Stiewe,et al.  KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. , 2008, Journal of the National Cancer Institute.

[82]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[83]  T. Lawrence,et al.  “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.

[84]  Jan Delabie,et al.  Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma , 2008, Science.

[85]  Kaneko,et al.  Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis , 2008 .

[86]  W. Pitts,et al.  Advances in the Discovery of IκB Kinase Inhibitors , 2008 .

[87]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2008, Nature.

[88]  M. Karin,et al.  IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells , 2007, Proceedings of the National Academy of Sciences.

[89]  T. Bosch,et al.  The evolution of immunity: a low-life perspective. , 2007, Trends in immunology.

[90]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[91]  L. Staudt,et al.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.

[92]  L. Bruhn,et al.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.

[93]  M. Feldmann,et al.  Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. , 2007, Current opinion in pharmacology.

[94]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[95]  Eric S. Lander,et al.  Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.

[96]  G. Stark,et al.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. , 2007, Genes & development.

[97]  Christian Haslinger,et al.  p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway , 2007, Nature Genetics.

[98]  A. Osterman,et al.  Bcl-2 and Bcl-XL Regulate Proinflammatory Caspase-1 Activation by Interaction with NALP1 , 2007, Cell.

[99]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[100]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[101]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[102]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[103]  Hua Yu,et al.  Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.

[104]  Michael Karin,et al.  Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.

[105]  M. Silva,et al.  IKKβ inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis , 2006 .

[106]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[107]  Liming Yang,et al.  A loss-of-function RNA interference screen for molecular targets in cancer , 2006, Nature.

[108]  Y. Carmi,et al.  Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. , 2006, European journal of cancer.

[109]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[110]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[111]  A. Gottlieb,et al.  Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept , 2005 .

[112]  Masakazu Toi,et al.  Nuclear factor-κB inhibitors as sensitizers to anticancer drugs , 2005, Nature Reviews Cancer.

[113]  L. Staudt,et al.  Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling , 2005 .

[114]  Epithelial proliferation and morphogenesis of hyperplastic adenomatous and villous polyps of the human colon , 2005, Virchows Archiv A.

[115]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[116]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[117]  Debajit K. Biswas,et al.  NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis , 2004 .

[118]  E. Harhaj,et al.  Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.

[119]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[120]  M. Genovese,et al.  Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. , 2004, Arthritis and rheumatism.

[121]  J. Adams,et al.  Development of the Proteasome Inhibitor Velcade™ (Bortezomib) , 2004, Cancer investigation.

[122]  M. Karin,et al.  NF-κB in Mammary Gland Development and Breast Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.

[123]  T. Gilmore,et al.  The Rel/NF-κB/IκB Signal Transduction Pathway and Cancer , 2004 .

[124]  D. Dambach,et al.  An inhibitor of IκB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice , 2003, Inflammation Research.

[125]  W. Müller,et al.  Origin of metazoan stem cell system in sponges: first approach to establish the model (Suberites domuncula). , 2003, Biomolecular engineering.

[126]  M. Karin,et al.  The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion , 2003, Nature Medicine.

[127]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[128]  B. Carter,et al.  Activation of the transcription factor NF-κB in Schwann cells is required for peripheral myelin formation , 2003, Nature Neuroscience.

[129]  R. Serra,et al.  TGF-β in Mammary Gland Development and Breast Cancer , 2003 .

[130]  T. Gilmore,et al.  The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. , 2003, Cancer treatment and research.

[131]  M. Oren,et al.  Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53. , 2003, Cancer research.

[132]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[133]  C. Duckett.  Apoptosis and NF-κB: the FADD connection , 2002 .

[134]  T. Lawrence,et al.  Possible new role for NF-κB in the resolution of inflammation , 2001, Nature Medicine.

[135]  P. Tak,et al.  Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation , 2001 .

[136]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[137]  M. Feldmann,et al.  Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFκB in tumour necrosis factor production , 2000, Annals of the rheumatic diseases.

[138]  E. Koonin,et al.  Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. , 2000, Molecular cell.

[139]  Steffen Jung,et al.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation , 2000, Nature Medicine.

[140]  J. Madara,et al.  Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated activation of the NF-kappaB pathway. , 2000, The Journal of clinical investigation.

[141]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[142]  Y. Barenholz,et al.  Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[143]  M. Dyer,et al.  Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types , 1999, Cell.

[144]  M. Mann,et al.  Identification of the receptor component of the IκBα–ubiquitin ligase , 1998, Nature.

[145]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[146]  M. Dyer,et al.  Bcl 10 Is Involved in t ( 1 ; 14 ) ( p 22 ; q 32 ) of MALT B Cell Lymphoma and Mutated in Multiple Tumor , 1998 .

[147]  B. Aggarwal,et al.  Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: Role of the nuclear transcription factor NF‐xB , 1997, European journal of immunology.

[148]  D. Männel,et al.  Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.

[149]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[150]  D. Männel,et al.  Role of NF k B in the Mortality of Sepsis , 1997 .

[151]  M. Neurath,et al.  Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.

[152]  D. Baltimore,et al.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.

[153]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[154]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[155]  N. Harpaz,et al.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. , 1993, Gastroenterology.

[156]  V. Bours,et al.  The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition , 1992, Nature.

[157]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.

[158]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[159]  I. Berenblum.  Challenging problems in cocarcinogenesis. , 1985, Cancer research.

[160]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[161]  D. Squires.  Neoplasia in a Coral? , 1965, Science.

[162]  J. W. Cole,et al.  Studies on the morphogenesis of adenomatous polyps in the human colon , 1963, Cancer.